Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Roche opens media buying review

Published on .

Roche Laboratories, Nutley, N.J., is reviewing general media buying and direct media buying duties for fat-fighting drug Xenical and influenza drug Tamiflu. Media and direct agencies have received RFPs from AAR/Bob Wolf Partners, New York, regarding the assignments. Total spending is estimated at $40 million to $50 million. General and direct media buying incumbents Impiric, Media Marketing Solutions and Media Direct Partners were invited to compete, according to executives close to the review.

Copyright August 2000, Crain Communications Inc.

Most Popular
In this article: